Iovance Biotherapeutics Insider Trades

IOVA

Track insider trading activity from Iovance Biotherapeutics executives and directors. See which insiders are buying and selling IOVA stock.

Trades Last 12 Months

IOVA Price

All Insider Trades for Iovance Biotherapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Vogt Frederick G Interim CEO & General Counsel
Holding Value $8.92M 602,085 shares
Last Trade
Sep 08, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$136k 15,626 shares
$8.70
$14.82
Bilinsky Igor Chief Operating Officer
Holding Value $695k 46,878 shares
Last Trade
Sep 08, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$68k 7,813 shares
$8.70
$14.82
Puri Raj K. Chief Regulatory Officer
Holding Value $3.87M 260,842 shares
Last Trade
Sep 08, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$85k 9,766 shares
$8.70
$14.82
Kirby Daniel Gordon Chief Commercial Officer
Holding Value $889k 60,003 shares
Last Trade
Aug 10, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$64k 10,001 shares
$6.40
$14.82
Roche Corleen M. Chief Financial Officer
Holding Value $426k 28,757 shares
Last Trade
Aug 06, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$132k 21,238 shares
$6.21
$14.82
Dukes Iain D. Director
Holding Value $2.68M 180,632 shares
Last Trade
Jun 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$728k 180,632 shares
$4.03
$14.82
Maynard Ryan D Director
Holding Value $1.34M 90,316 shares
Last Trade
Jun 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$364k 90,316 shares
$4.03
$14.82
Holding Value $1.34M 90,316 shares
Last Trade
Jun 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$364k 90,316 shares
$4.03
$14.82
Weiser Michael Director
Holding Value $1.34M 90,316 shares
Last Trade
Jun 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$364k 90,316 shares
$4.03
$14.82
Graf Finckenstein Friedrich Chief Medical Officer
Holding Value $2.08M 140,111 shares
Last Trade
Jun 05, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$16.8k 3,976 shares
$4.23
$14.82
Graf Finckenstein Friedrich Chief Medical Officer
Holding Value $871k 58,750 shares
Last Trade
Mar 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$318k 58,750 shares
$5.41
$14.82
Bilinsky Igor Chief Operating Officer
Holding Value $1.74M 117,500 shares
Last Trade
Mar 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$636k 117,500 shares
$5.41
$14.82
Rosinack Matthew W. Svp, Finance (int. PFO & Pao)
Holding Value $1.32M 89,129 shares
Last Trade
Jun 30, 2025 Sale
$129k 75,000 shares
$1.72
$14.82
Yarno Wendy L Director
Holding Value $1M 67,546 shares
Last Trade
Jun 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$151k 67,546 shares
$2.24
$14.82
Weiser Michael Director
Holding Value $1M 67,546 shares
Last Trade
Jun 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$151k 67,546 shares
$2.24
$14.82
Bellemin Jean Marc Chief Financial Officer
Holding Value $912k 61,528 shares
Last Trade
Jun 02, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$15.5k 8,789 shares
$1.76
$14.82
Holding Value $1.48M 100,000 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.68M 100,000 shares
$16.79
$14.82
Mcpeak Merrill A Director
Holding Value $741k 50,000 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$840k 50,000 shares
$16.79
$14.82
Dixon Wendy L Director
Holding Value $759k 51,204 shares
Last Trade
Jun 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$425k 51,204 shares
$8.30
$14.82
Fardis Maria President And CEO
Holding Value $3.71M 250,000 shares
Last Trade
Jan 04, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.6M 250,000 shares
$46.26
$14.82

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up